PTC Therapeutics | PTCT - Cost Of Sales

Stock Price
74.68
Daily Change
2.32 3.21%
Monthly
-3.31%
Yearly
50.96%
Q1 Forecast
73.20

PTC Therapeutics reported $23.32M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Acadia Pharmaceuticals USD 21.65M 913K Sep/2025
Alnylam Pharmaceuticals USD 200.15M 57.2M Sep/2025
Amgen USD 1.79B 128M Dec/2025
Biogen USD 810.1M 205.1M Sep/2025
BioMarin Pharmaceutical USD 144.93M 10M Sep/2025
Cytokinetics USD 112.55M 12.71M Jun/2025
Daiichi Sankyo JPY 118.28B 37.7B Dec/2025
Gilead Sciences USD 1.57B 68M Sep/2025
Incyte USD 99M 20.23M Sep/2025
Ionis Pharmaceuticals USD 2.34M 1.81M Sep/2025
Ironwood Pharmaceuticals USD 29.83M 560K Sep/2024
Novartis USD 3.54B 217M Sep/2025
Pfizer USD 6.29B 2.12B Dec/2025
PTC Therapeutics USD 23.32M 7.83M Sep/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Sarepta Therapeutics USD 151.45M 1.77M Sep/2025
TG Therapeutics USD 28.09M 9.15M Sep/2025
Ultragenyx Pharmaceutical USD 27.99M 4.99M Sep/2025
Vertex Pharmaceuticals USD 414.8M 7.3M Sep/2025
Xencor USD 61.66M 50.95M Jun/2025